Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Therapeutic Targeting of the Tumor MicroenvironmentCancer discovery, 2021-04, Vol.11 (4), p.933-9592021 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-20-1808 ;PMID: 33811125Full text available |
|
2 |
Material Type: Article
|
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating HypoxiaCancer cell, 2014-11, Vol.26 (5), p.605-622 [Peer Reviewed Journal]2014 Elsevier Inc. ;Copyright © 2014 Elsevier Inc. All rights reserved. ;2014 Elsevier Inc. All rights reserved. 2014 ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2014.10.006 ;PMID: 25517747Full text available |
|
3 |
Material Type: Article
|
Current treatment and recent progress in gastric cancerCA: a cancer journal for clinicians, 2021-05, Vol.71 (3), p.264-279 [Peer Reviewed Journal]2021 American Cancer Society ;2021 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. May/Jun 2021 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21657 ;PMID: 33592120Full text available |
|
4 |
Material Type: Article
|
Tumor angiogenesis: causes, consequences, challenges and opportunitiesCellular and molecular life sciences : CMLS, 2020-05, Vol.77 (9), p.1745-1770 [Peer Reviewed Journal]The Author(s) 2019 ;The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1420-682X ;ISSN: 1420-9071 ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-019-03351-7 ;PMID: 31690961Full text available |
|
5 |
Material Type: Article
|
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer TherapyClinical cancer research, 2023-01, Vol.29 (1), p.30-39 [Peer Reviewed Journal]2022 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-22-1366 ;PMID: 35969170Full text available |
|
6 |
Material Type: Article
|
The impact of VEGF on cancer metastasis and systemic diseaseSeminars in cancer biology, 2022-11, Vol.86 (Pt 3), p.251 [Peer Reviewed Journal]ISSN: 1096-3650 ;EISSN: 1096-3650 ;DOI: 10.1016/j.semcancer.2022.03.011Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Treatment of muscle‐invasive and advanced bladder cancer in 2020CA: a cancer journal for clinicians, 2020-09, Vol.70 (5), p.404-423 [Peer Reviewed Journal]2020 American Cancer Society ;2020 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Sep/Oct 2020 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21631 ;PMID: 32767764Full text available |
|
8 |
Material Type: Article
|
The Role of Angiogenesis in Hepatocellular CarcinomaClinical cancer research, 2019-02, Vol.25 (3), p.912-920 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-1254 ;PMID: 30274981Full text available |
|
9 |
Material Type: Article
|
Ten years of anti-vascular endothelial growth factor therapyNature reviews. Drug discovery, 2016-06, Vol.15 (6), p.385-403 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2015.17 ;PMID: 26775688Full text available |
|
10 |
Material Type: Article
|
Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both?Cancer research (Chicago, Ill.), 2022-01, Vol.82 (1), p.15-17 [Peer Reviewed Journal]2022 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-21-3515 ;PMID: 34983784Full text available |
|
11 |
Material Type: Article
|
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challengesNature reviews. Clinical oncology, 2018-05, Vol.15 (5), p.325-340 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group May 2018 ;Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2018. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2018.29 ;PMID: 29508855Full text available |
|
12 |
Material Type: Article
|
Therapeutic targeting of the angiopoietin-TIE pathwayNature reviews. Drug discovery, 2017-09, Vol.16 (9), p.635-661 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2017 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.278 ;PMID: 28529319Full text available |
|
13 |
Material Type: Article
|
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trialThe Lancet (British edition), 2017-02, Vol.389 (10068), p.519-527 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 4, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31594-X ;PMID: 28017406 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
Macrophage Regulation of Tumor Responses to Anticancer TherapiesCancer cell, 2013-03, Vol.23 (3), p.277-286 [Peer Reviewed Journal]2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccr.2013.02.013 ;PMID: 23518347Full text available |
|
15 |
Material Type: Article
|
Anti-angiogenic agents - overcoming tumour endothelial cell anergy and improving immunotherapy outcomesNature reviews. Clinical oncology, 2021-08, Vol.18 (8), p.527-540 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-021-00496-y ;PMID: 33833434Full text available |
|
16 |
Material Type: Article
|
Basic and Therapeutic Aspects of AngiogenesisCell, 2011-09, Vol.146 (6), p.873-887 [Peer Reviewed Journal]2011 Elsevier Inc. ;Copyright © 2011 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2011.08.039 ;PMID: 21925313Full text available |
|
17 |
Material Type: Article
|
Tumor angiogenesis and vascular normalization: alternative therapeutic targetsAngiogenesis (London), 2017-11, Vol.20 (4), p.409-426 [Peer Reviewed Journal]Springer Science+Business Media B.V. 2017 ;Angiogenesis is a copyright of Springer, 2017. ;ISSN: 0969-6970 ;EISSN: 1573-7209 ;DOI: 10.1007/s10456-017-9562-9 ;PMID: 28660302Full text available |
|
18 |
Material Type: Article
|
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic ApproachesInternational journal of molecular sciences, 2016-09, Vol.17 (9), p.1534-1534 [Peer Reviewed Journal]2016 by the authors; licensee MDPI, Basel, Switzerland. 2016 ;ISSN: 1422-0067 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms17091534 ;PMID: 27649147Full text available |
|
19 |
Material Type: Article
|
Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directionsBritish journal of ophthalmology, 2022-03, Vol.106 (3), p.297-304 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-318452 ;PMID: 33741584Full text available |
|
20 |
Material Type: Article
|
Vascular normalisation as the stepping stone into tumour microenvironment transformationBritish journal of cancer, 2021-08, Vol.125 (3), p.324-336 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01330-z ;PMID: 33828258Full text available |